Cell Stem Cell:皮肤癌起始、生长及恶化的分子机制

2015-01-13 佚名 生物谷

鳞状细胞癌是第二大常见的皮肤癌,每年在全世界都会有超过50万人深受该疾病的影响;而癌症干细胞是存在于许多癌症中的一小部分癌细胞,包括皮肤癌症干细胞等,这些干细胞可以促进癌症发展,使得癌症对疗法产生耐受性从而使患者化疗失败,然而目前研究人员对于调节癌症干细胞的机制却知之甚少。 近日,一篇发表于国际杂志Cell Stem Cell上的研究论文中,来自布鲁塞尔自由大学的研究人员通过研究发现,Twi

鳞状细胞癌是第二大常见的皮肤癌,每年在全世界都会有超过50万人深受该疾病的影响;而癌症干细胞是存在于许多癌症中的一小部分癌细胞,包括皮肤癌症干细胞等,这些干细胞可以促进癌症发展,使得癌症对疗法产生耐受性从而使患者化疗失败,然而目前研究人员对于调节癌症干细胞的机制却知之甚少。

近日,一篇发表于国际杂志Cell Stem Cell上的研究论文中,来自布鲁塞尔自由大学的研究人员通过研究发现,Twist1可以调节皮肤肿瘤的生长、癌症干细胞的功能抑制肿瘤的恶化;研究者Benjamin Beck表示,我们利用遗传小鼠来进行研究,阐明Twist1控制肿瘤起始,癌症干细胞的功能以及肿瘤恶化的分子机制。

Twist1并不在正常皮肤中进行表达,Twist1的剔除可以抑制皮肤癌的发生,这就表明其在肿瘤形成过程中发挥着重要作用,研究者很惊讶地发现Twist1在肿瘤形成的早期阶段扮演着重要角色,而此前他们认为Twist1仅可以刺激肿瘤恶化和转移。

不同水平的Twist1对于肿瘤的起始及进展非常必要,低水平的Twist1是良性肿瘤发生所必需的,而高水平的Twist1则对于肿瘤的维持及癌症干细胞功能的调节非常重要。同时研究人员也揭示了Twist1可以被不同的分子机制所调节并且发挥不同的功能,Twist1在调节癌症干细胞功能上并不依赖于p53。

总的来讲,本文研究研究人员揭示了广为人知的可以调节肿瘤进展的分子Twist1的新型功能,为后期研究人员理解癌症发生、发展、转移以及恶化提供了新的研究线索,也为开发针对癌症的靶向疗法提供了新的希望。

原始出处

Benjamin Beck, Gaëlle Lapouge, Sandrine Rorive.Different Levels of Twist1 Regulate Skin Tumor Initiation, Stemness, and Progression.Cell Stem Cell.2014.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1868991, encodeId=649d186899102, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sat Sep 26 21:04:00 CST 2015, time=2015-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959242, encodeId=58691959242ca, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Thu Jun 11 00:04:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1794378, encodeId=d0f61e9437803, content=<a href='/topic/show?id=82b416e79f5' target=_blank style='color:#2F92EE;'>#stem cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16779, encryptionId=82b416e79f5, topicName=stem cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Jul 25 19:04:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481852, encodeId=20421481852b1, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Thu Jan 15 00:04:00 CST 2015, time=2015-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14086, encodeId=f37214086c4, content=癌干细胞?, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=116.226.156.**, createdTime=Tue Jan 13 16:20:00 CST 2015, time=2015-01-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1868991, encodeId=649d186899102, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sat Sep 26 21:04:00 CST 2015, time=2015-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959242, encodeId=58691959242ca, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Thu Jun 11 00:04:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1794378, encodeId=d0f61e9437803, content=<a href='/topic/show?id=82b416e79f5' target=_blank style='color:#2F92EE;'>#stem cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16779, encryptionId=82b416e79f5, topicName=stem cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Jul 25 19:04:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481852, encodeId=20421481852b1, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Thu Jan 15 00:04:00 CST 2015, time=2015-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14086, encodeId=f37214086c4, content=癌干细胞?, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=116.226.156.**, createdTime=Tue Jan 13 16:20:00 CST 2015, time=2015-01-13, status=1, ipAttribution=)]
    2015-06-11 维他命
  3. [GetPortalCommentsPageByObjectIdResponse(id=1868991, encodeId=649d186899102, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sat Sep 26 21:04:00 CST 2015, time=2015-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959242, encodeId=58691959242ca, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Thu Jun 11 00:04:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1794378, encodeId=d0f61e9437803, content=<a href='/topic/show?id=82b416e79f5' target=_blank style='color:#2F92EE;'>#stem cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16779, encryptionId=82b416e79f5, topicName=stem cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Jul 25 19:04:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481852, encodeId=20421481852b1, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Thu Jan 15 00:04:00 CST 2015, time=2015-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14086, encodeId=f37214086c4, content=癌干细胞?, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=116.226.156.**, createdTime=Tue Jan 13 16:20:00 CST 2015, time=2015-01-13, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1868991, encodeId=649d186899102, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sat Sep 26 21:04:00 CST 2015, time=2015-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959242, encodeId=58691959242ca, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Thu Jun 11 00:04:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1794378, encodeId=d0f61e9437803, content=<a href='/topic/show?id=82b416e79f5' target=_blank style='color:#2F92EE;'>#stem cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16779, encryptionId=82b416e79f5, topicName=stem cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Jul 25 19:04:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481852, encodeId=20421481852b1, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Thu Jan 15 00:04:00 CST 2015, time=2015-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14086, encodeId=f37214086c4, content=癌干细胞?, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=116.226.156.**, createdTime=Tue Jan 13 16:20:00 CST 2015, time=2015-01-13, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1868991, encodeId=649d186899102, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Sat Sep 26 21:04:00 CST 2015, time=2015-09-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1959242, encodeId=58691959242ca, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c3ff68, createdName=维他命, createdTime=Thu Jun 11 00:04:00 CST 2015, time=2015-06-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1794378, encodeId=d0f61e9437803, content=<a href='/topic/show?id=82b416e79f5' target=_blank style='color:#2F92EE;'>#stem cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16779, encryptionId=82b416e79f5, topicName=stem cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sat Jul 25 19:04:00 CST 2015, time=2015-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1481852, encodeId=20421481852b1, content=<a href='/topic/show?id=8cc416e78f3' target=_blank style='color:#2F92EE;'>#STEM#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16778, encryptionId=8cc416e78f3, topicName=STEM)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d1067833268, createdName=12498bb3m92(暂无昵称), createdTime=Thu Jan 15 00:04:00 CST 2015, time=2015-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=14086, encodeId=f37214086c4, content=癌干细胞?, beContent=null, objectType=article, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=116.226.156.**, createdTime=Tue Jan 13 16:20:00 CST 2015, time=2015-01-13, status=1, ipAttribution=)]
    2015-01-13 116.226.156.**

    癌干细胞?

    0

相关资讯

J Invest Dermatol:常见止痛药可助于预防某些皮肤癌

普通止痛药包括布洛芬,可能会略降低患上皮肤癌的风险。研究人员回顾9项以前的研究后得出结论,使用布洛芬和萘普生,鳞状细胞皮肤癌的风险15%降低。鳞状细胞皮肤癌通常是由太阳暴晒引起的。 这些止痛药有潜力成为皮肤癌预防战略的一部分。但研究人员都没有准备好推荐这些或其他非甾体抗炎药(NSAIDs)以防止皮肤癌。Joshua Zeichner博士表示:不要依靠服用阿司匹林或其他非甾体类抗炎药,以保护你的皮

外表不自信的人易患皮肤癌

据英国《每日邮报》10月14日报道,近期研究表明,对于自己的外表感到不自信的人群,患皮肤癌的机率可能增大。 近期一项研究表明,对自己外表不满意的人群,为了拥有健康理想的小麦肤色,他们会选择日光浴这一方式来达到目的,并且很少涂抹防晒霜。 英、美学者称,这类人的这一做法,或许只是希望通过健康红润的肤色来增加颜值。然而,他们大都忽视了日光浴对皮肤带来的危害。当皮肤完全暴露在强烈的阳光下且没有保护措施

GSK皮肤癌药物Mekinist获欧盟批准

葛兰素史克(GSK)的Mekinist近日赢得了欧洲药品管理局(EMA)的批准用于黑色素瘤的治疗,成为第一种在在欧洲批准授权的MEK抑制剂类药物。 Mekinist(trametinib)已在欧盟批准作为单一治疗药物用于携带BRAFV600突变的不可切除或转移性黑色素瘤成人患者。 这次批准通过对于葛兰素史克公司和诺华公司都是一个好消息,诺华曾与GSK达成了一项协议,以160亿美元从GSK收购M

Rev Sci Instrum:新型皮肤癌检测探针问世

近日,来自德州大学的研究人员通过研究开发了一种新型探针,其可以将三种特殊的方法集于一种设备,利用光来检测皮肤组织的特性以及进行癌症的检测;研究者表示,目前这种新型的三合一探针正在进行先期临床试验,相关研究成果刊登于国际杂志Review of Scientific Instruments上。 在北美所有类型的皮肤癌在患者中都较为常见,而黑色素瘤,致死率最高的皮肤癌,其也是引发癌症死

Rev Sci Instrum:一种新型的皮肤癌三合一光学检测探针

近日,来自德州大学的研究人员通过研究开发了一种新型探针,其可以将三种特殊的方法集于一种设备,利用光来检测皮肤组织的特性以及进行癌症的检测;研究者表示,目前这种新型的三合一探针正在进行先期临床试验,相关研究成果刊登于国际杂志Review of Scientific Instruments上。在北美所有类型的皮肤癌在患者中都较为常见,而黑色素瘤,致死率最高的皮肤癌,其也是引发癌症死亡的主要原因,每年在

J Invest Derm:非甾体类抗炎药(NSAIDs)可能预防皮肤癌

据一项最新研究表明非甾体类抗炎药(NSAIDs)能够预防皮肤癌,该研究发表于近日的Journal of Investigative Dermatology上。NSAID可以降低大肠癌、肺癌、乳腺癌和前列腺癌的发病风险,但是还没有证据表明它能够预防皮肤癌。Chiho Muranushi及其同事根据已发表的文献进行了meta分析,研究了阿司匹林、非阿司匹林类NSAIDs以及其他NSAIDs类药物对鳞状